Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Westermann

Showing results (41-50 of 532) with videos related to

Pageof 54
Sort By:
Integrated Blood Pressure Control|September 28, 2011
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combinationKonstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Journal of Molecular and Cellular Cardiology|September 5, 2009
Immunomodulation and matrix metalloproteinases in viral myocarditisDirk Westermann, Konstantinos Savvatis, Heinz-Peter Schultheiss, et al.
World Journal of Cardiology|September 29, 2015
Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?"Peter Moritz Becher, Nina Fluschnik, Stefan Blankenberg, et al.
Neuropeptides|December 29, 2009
Kinins in cardiac inflammation and regeneration: insights from ischemic and diabetic cardiomyopathyKonstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 26, 2008
Renin inhibitors, clinical experienceDirk Westermann, Roland Schmieder, Heinz-Peter Schultheiss, et al.
JTCVS Open|August 25, 2022
Extracorporeal membrane oxygenation evolution: Left ventricular unloading strategiesAlexander M Bernhardt, Benedikt Schrage, Dirk Westermann, et al.
Cardiology Research and Practice|November 20, 2013
Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?Jia Li, Peter Moritz Becher, Stefan Blankenberg, et al.
Circulation|September 10, 2019
Response by Schrage et al to Letter Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis"Benedikt Schrage, Steffen Schneider, Uwe Zeymer, et al.
Cardiology Research and Practice|July 9, 2011
Heart failureGregory Giamouzis, Filippos Triposkiadis, Javed Butler, et al.
Nature Reviews. Cardiology|April 7, 2017
High-sensitivity assays for troponin in patients with cardiac diseaseDirk Westermann, Johannes Tobias Neumann, Nils Arne Sörensen, et al.
Pageof 54

Showing results (41-50 of 532) with videos related to

Sort By:
Pageof 54
Integrated Blood Pressure Control|September 28, 2011
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combinationKonstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Journal of Molecular and Cellular Cardiology|September 5, 2009
Immunomodulation and matrix metalloproteinases in viral myocarditisDirk Westermann, Konstantinos Savvatis, Heinz-Peter Schultheiss, et al.
World Journal of Cardiology|September 29, 2015
Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?"Peter Moritz Becher, Nina Fluschnik, Stefan Blankenberg, et al.
Neuropeptides|December 29, 2009
Kinins in cardiac inflammation and regeneration: insights from ischemic and diabetic cardiomyopathyKonstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 26, 2008
Renin inhibitors, clinical experienceDirk Westermann, Roland Schmieder, Heinz-Peter Schultheiss, et al.
JTCVS Open|August 25, 2022
Extracorporeal membrane oxygenation evolution: Left ventricular unloading strategiesAlexander M Bernhardt, Benedikt Schrage, Dirk Westermann, et al.
Cardiology Research and Practice|November 20, 2013
Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?Jia Li, Peter Moritz Becher, Stefan Blankenberg, et al.
Circulation|September 10, 2019
Response by Schrage et al to Letter Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis"Benedikt Schrage, Steffen Schneider, Uwe Zeymer, et al.
Cardiology Research and Practice|July 9, 2011
Heart failureGregory Giamouzis, Filippos Triposkiadis, Javed Butler, et al.
Nature Reviews. Cardiology|April 7, 2017
High-sensitivity assays for troponin in patients with cardiac diseaseDirk Westermann, Johannes Tobias Neumann, Nils Arne Sörensen, et al.
Pageof 54